1,049
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice

, , , , , , , , , , , & show all
Article: 2268753 | Received 14 Aug 2023, Accepted 04 Oct 2023, Published online: 19 Oct 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.